Company Filing History:
Years Active: 2021-2022
Title: Innovations in Stroke Treatment by Muhammad Hussain Al-Qahtani
Introduction
Muhammad Hussain Al-Qahtani is a notable inventor based in Jeddah, Saudi Arabia. He has made significant contributions to the field of medical science, particularly in the treatment of stroke patients with comorbidities. With a total of 4 patents to his name, Al-Qahtani's work focuses on innovative therapies that enhance patient outcomes.
Latest Patents
Al-Qahtani's latest patents include groundbreaking research on GSNO reductase inhibitors as adjunct therapies in cerebral thrombosis and thromboembolic stroke. His work addresses the challenges faced by stroke patients who also suffer from conditions such as diabetes and hypertension. The patents detail the administration of an inhibitor of S-nitrosoglutathione reductase (GSNOR) alongside remote ischemic conditioning (RIC) to improve treatment efficacy. This combination has shown promise in enhancing the effectiveness of intravenous tissue plasminogen activator therapy (IVT) and endovascular thrombectomy (EVT) even after five hours post-onset of stroke.
Career Highlights
Al-Qahtani is affiliated with King Abdulaziz University, where he conducts research and develops innovative medical solutions. His dedication to improving stroke treatment has positioned him as a key figure in the medical research community. His work not only contributes to academic knowledge but also has the potential to save lives through improved therapeutic strategies.
Collaborations
Al-Qahtani collaborates with esteemed colleagues such as Syed Kashif Zaidi and Md Nasrul Hoda. These partnerships enhance the research efforts and broaden the scope of their innovative projects.
Conclusion
Muhammad Hussain Al-Qahtani's contributions to stroke treatment through his innovative patents reflect his commitment to advancing medical science. His work has the potential to significantly improve the quality of care for patients with complex health conditions.